Left ventricular dysfunction in duchenne muscular dystrophy and genotype.

Area of Science:

• Cardiology
• Genetics
• Neuromuscular Disorders

Background:

• Duchenne muscular dystrophy (DMD) prognosis is often guarded, with cardiac and respiratory failure being leading causes of mortality.
• The relationship between specific DMD gene mutations and the severity of cardiac dysfunction remains unclear.
• Left ventricular (LV) dysfunction exhibits significant variability among DMD patients.

Purpose of the Study:

• To investigate whether specific Duchenne muscular dystrophy gene mutations correlate with the severity of cardiac dysfunction.
• To analyze the variability in left ventricular function and its relationship with genetic mutations in DMD patients.

Main Methods:

• Studied 75 Duchenne muscular dystrophy patients.
• Assessed cardiac function annually using echocardiography.
• Collected genetic data, focusing on mutation location (exon 1-20 vs. 41-55) and number of exons involved (<5 vs. ≥5).
• Defined four severity groups for LV dysfunction based on age of onset and degree of dysfunction.

Main Results:

• Significant variability in left ventricular function was observed, with some patients showing minimal dysfunction in their 30s and others severe dysfunction in their 20s.
• No significant difference in the distribution of LV dysfunction severity was found between mutation groups (exon 1-20 vs. 41-55) or based on the number of exons involved.
• Concordance in cardiac course was often not evident even among patients with identical mutations.
• Steroid therapy did not appear to protect against the development of cardiomyopathy.

Conclusions:

• Duchenne muscular dystrophy patients exhibit marked variability in left ventricular dysfunction severity.
• Neither the age of onset nor the severity of cardiomyopathy correlated with specific mutation groups in DMD.
• Genetic mutations do not reliably predict cardiac involvement severity in Duchenne muscular dystrophy.